SynthesisFrontiers in pharmacology2024

Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023.

Xia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.